Rezdiffra.

View On IPO.GOV.UK

Registered

on 26 Apr 2024

Last Applicant/ Owned by

Madrigal Pharmaceuticals, Inc.

200 Barr Harbor Drive, Suite 200

West Conshohocken, Pennsylvania, 19428

Serial Number

UK00004044447 filed on 26^th Apr 2024

Registration Number

UK00004044447 registered on
19^th Jul 2024

Correspondent Information

Morgan, Lewis & Bockius UK LLP

Condor House, 5-10 St. Paul's Churchyard

London,

EC4M 8AL

Rezdiffra.

pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (nash) with liver fibrosis.

Classification Information

Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis.

UK00004044447

Figurative

Individual